| Intraoperative Evaluation of Axillary Lymphatics (NCT05094102) | University of Wisconsin, Madison | 2022-05-05 |
| LIMBO : Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté (NCT06101732) | Centre Hospitalier Universitaire de Besancon | 2022-05-05 |
| Social Risk Factors and Discrimination in Cancer Survivorship (NCT05301114) | Medstar Health Research Institute | 2022-05-05 |
| Time Restricted Eating on Cancer Risk (NCT05038137) | Medical University of South Carolina | 2022-05-04 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials (NCT06361056) | UNC Lineberger Comprehensive Cancer Center | 2022-05-02 |
| Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP) (NCT05363189) | Vastra Gotaland Region | 2022-05-02 |
| Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer (NCT04656639) | Seoul National University Hospital | 2022-05-01 |
| Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia (NCT05397457) | Chang Gung Memorial Hospital | 2022-05-01 |
| Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer (NCT05307757) | Seoul National University Hospital | 2022-05-01 |
| AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer (NCT05302336) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-05-01 |
| The HIFUB Study (HIFU in Breast Cancer) (NCT05350059) | University of Oxford | 2022-05-01 |
| Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen (NCT05731258) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-05-01 |
| 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes (NCT05412446) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2022-05-01 |
| Relationship Between Breast Cancer Subtypes and Immune Checkpoints (NCT05460702) | Istanbul Training and Research Hospital | 2022-05-01 |
| The Effect of the Motivational Interviewing Technique on Breast and Cervical Cancer Screenings (NCT05353387) | Istanbul Saglik Bilimleri University | 2022-04-30 |
| Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy (NCT05951699) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-04-28 |
| Mapping Arterial Perforators Within the Breast During Mammoplasty (NCT06347952) | Royal Marsden NHS Foundation Trust | 2022-04-27 |
| Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity (NCT05371847) | KU Leuven | 2022-04-26 |
| Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment (NCT05297591) | KU Leuven | 2022-04-26 |
| A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer (NCT05346224) | Shanghai Henlius Biotech | 2022-04-25 |
| TCM as an Adjuvant Treatment in Breast Cancer Patients (NCT04843865) | Universiti Tunku Abdul Rahman | 2022-04-22 |
| Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy (NCT06299930) | Seoul National University Hospital | 2022-04-22 |
| Michigan Genetic Hereditary Testing (MiGHT) (NCT05162846) | University of Michigan Rogel Cancer Center | 2022-04-21 |
| Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer (NCT04791384) | Criterium, Inc. | 2022-04-21 |
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan (NCT05399329) | Pfizer | 2022-04-20 |
| Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer (NCT05251766) | Xuli Meng | 2022-04-20 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours (NCT05363605) | Fusion Pharmaceuticals Inc. | 2022-04-20 |
| Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery (NCT05914792) | University of Pittsburgh | 2022-04-19 |
| Opt-in vs. Opt-out for Breast Cancer Screening (NCT05313737) | VA Puget Sound Health Care System | 2022-04-18 |
| The DIALOGUE Study: Swiss-Korean Billateral Collaboration (NCT04214210) | University of Basel | 2022-04-15 |
| RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) (NCT05176756) | Abramson Cancer Center at Penn Medicine | 2022-04-14 |
| A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors (NCT05070247) | Takeda | 2022-04-14 |
| Smart Bra for Diagnosing Breast Cancer (NCT05294016) | Hopital Nord Franche-Comte | 2022-04-13 |
| Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients (NCT05351021) | Mansoura University | 2022-04-12 |
| The PAI Trial for Breast and Colon Cancer Survivors (NCT05156463) | Milton S. Hershey Medical Center | 2022-04-12 |
| An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study) (NCT05263362) | Erasmus Medical Center | 2022-04-11 |
| A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients (NCT05365191) | National Taiwan University Hospital Hsin-Chu Branch | 2022-04-08 |
| A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients (NCT05365204) | National Taiwan University Hospital Hsin-Chu Branch | 2022-04-08 |
| A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer (NCT05258747) | Sandoz | 2022-04-07 |
| Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study) (NCT05258526) | Hospital de Clinicas de Porto Alegre | 2022-04-07 |
| Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant (NCT04899349) | Novartis Pharmaceuticals | 2022-04-06 |
| Therapeutic Dose Monitoring (TDM) of Tamoxifen (NCT05133674) | Karolinska University Hospital | 2022-04-04 |
| Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians (NCT06416293) | University Hospital Augsburg | 2022-04-01 |
| Real-world Study of UTD1 in Chinese Advanced Breast Cancer (NCT05386511) | Fudan University | 2022-04-01 |
| Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis (NCT04948840) | Centre Francois Baclesse, Luxembourg | 2022-04-01 |
| Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients (NCT05253170) | Seoul National University Bundang Hospital | 2022-04-01 |
| Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer (NCT05804916) | Peking Union Medical College Hospital | 2022-04-01 |
| Genetic Predictors of Response to Acupuncture for Cancer-related Fatigue Among Breast Cancer Patients After Chemotherapy (NCT05094310) | Affiliated Hospital of Qinghai University | 2022-04-01 |
| UCLA Breast Cancer Survivor Health Promotion Research Study (NCT05113485) | University of California, Los Angeles | 2022-04-01 |
| Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology (NCT05441098) | Chinese Academy of Medical Sciences | 2022-04-01 |
| Comparing the Quality of Analgesia With Pectoral Nerve Block and Serratus Plane Block in Modified Radical Mastectomy (NCT05224310) | Suez Canal University | 2022-04-01 |
| TAP vs QL for Postoperative Analgesia After DIEP Free Flap Breast Reconstruction (NCT05301595) | Ottawa Hospital Research Institute | 2022-04-01 |
| Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients (NCT05298072) | University Hospital, Essen | 2022-04-01 |
| Tridimensional Geometric Modeling of the Breast (NCT05301998) | University Hospital, Montpellier | 2022-03-31 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer (NCT07441330) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2022-03-31 |
| Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer (NCT05207514) | Samyang Biopharmaceuticals Corporation | 2022-03-31 |
| A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys (NCT04990895) | AHS Cancer Control Alberta | 2022-03-30 |
| The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population (NCT05090605) | Asfendiyarov Kazakh National Medical University | 2022-03-30 |
| Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen (NCT05591547) | Sanford Health | 2022-03-30 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| Oral Aromatase Inhibitors Modify the Gut Microbiome (NCT05030038) | Wake Forest University Health Sciences | 2022-03-29 |
| Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology (NCT05354882) | Université Sorbonne Paris Nord | 2022-03-29 |
| High-intensity Exercise After Treatment (NCT04950010) | University of Nebraska | 2022-03-28 |
| Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer (NCT05183126) | University of Michigan Rogel Cancer Center | 2022-03-28 |
| Efficacy of Cilostazol in Prevention of Peripheral Neuropathy (NCT05298696) | Mansoura University | 2022-03-28 |
| Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer (NCT05143229) | University of Kansas Medical Center | 2022-03-28 |
| Evaluating the Impact of an Equity Focused Dashboard and Clinical Support (NCT05278806) | Massachusetts General Hospital | 2022-03-24 |
| Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer (NCT05775822) | Centro Cardiologico Monzino | 2022-03-24 |
| Tolerance to Immunomodulatory Nutritional Therapy in Oncology Patients Undergoing Chemotherapy and Radiotherapy (NCT07021378) | D'Or Institute for Research and Education | 2022-03-23 |
| A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction (NCT05316324) | Memorial Sloan Kettering Cancer Center | 2022-03-23 |
| Hepatitis C Screening Paired With Mammography (NCT05067374) | University Hospital, Montpellier | 2022-03-23 |
| Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT (NCT05716958) | Lunit Inc. | 2022-03-22 |
| Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer (NCT05296577) | Henan Cancer Hospital | 2022-03-22 |
| GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy. (NCT05562518) | University Hospital, Ghent | 2022-03-21 |
| Effectiveness and Safety of Preoperative Magnetic Detection of Non-palpable Breast Lesions (NCT05327218) | Fondation Hôpital Saint-Joseph | 2022-03-20 |
| Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women (NCT05275361) | Washington University School of Medicine | 2022-03-18 |
| Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography (NCT04348123) | Case Comprehensive Cancer Center | 2022-03-15 |
| Sensitivity and Predictive Value of Frozen Section of Sentinel Lymph Node Biopsy in Post Neoadjuvant Setting (NCT06401590) | Aga Khan University | 2022-03-15 |
| Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study (NCT05070299) | University of Michigan Rogel Cancer Center | 2022-03-15 |
| Artificial Intelligence in Breast Cancer Screening Programs (NCT04949776) | Maimónides Biomedical Research Institute of Córdoba | 2022-03-15 |
| A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors (NCT05262400) | Pfizer | 2022-03-14 |
| Cardio-Oncology Rehabilitation Exercise (NCT05522959) | University of Toronto | 2022-03-14 |
| Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer (NCT05291910) | Chinese Academy of Medical Sciences | 2022-03-12 |
| Quantifying Systemic Immunosuppression to Personalize Cancer Therapy (NCT05621837) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-03-10 |
| Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases (NCT04711824) | Colette Shen | 2022-03-09 |
| BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity (NCT05051631) | Vanderbilt University Medical Center | 2022-03-09 |
| Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy (NCT05245812) | Deborah Farr, MD | 2022-03-08 |
| An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy (NCT05258461) | Peking Union Medical College Hospital | 2022-03-07 |
| TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes (NCT05462457) | Kliniken Essen-Mitte | 2022-03-07 |
| Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing (NCT04968964) | Washington University School of Medicine | 2022-03-07 |
| FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer (NCT05304962) | Regor Pharmaceuticals Inc. | 2022-03-04 |
| Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer (NCT05112536) | G1 Therapeutics, Inc. | 2022-03-03 |
| Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy (NCT05069038) | University of Nebraska | 2022-03-02 |
| Towards Early Detection of Breast Cancer in High Risk Population (NCT05268913) | University of Aberdeen | 2022-03-01 |
| Neoadjuvant Treatment of Breast Cancer (NCT05131893) | National Institute of Oncology, Hungary | 2022-03-01 |
| Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer (NCT05346510) | Shengjing Hospital | 2022-03-01 |
| Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection (NCT05236387) | Johns Hopkins University | 2022-03-01 |
| Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer (NCT05007444) | Hospital Universitario San Ignacio | 2022-03-01 |